(Q43906388)

27 November 2017

title

Expression and activity of antioxidants in the brain in progressive supranuclear palsy (English)

1 reference

27 November 2017

6

1 reference

27 November 2017

4

M Flint Beal

1 reference

27 November 2017

author name string

Ippolita Cantuti-Castelvetri

1

1 reference

27 November 2017

Christine E Keller-McGandy

2

1 reference

27 November 2017

David S Albers

3

1 reference

27 November 2017

Jean Paul Vonsattel

5

1 reference

27 November 2017

Sarah J Augood

7

1 reference

27 November 2017

language of work or name

English

0 references

publication date

1 March 2002

1 reference

27 November 2017

number of pages

12

1 reference

based on heuristic

inferred from page(s)

published in

Brain Research

1 reference

27 November 2017

volume

930

1 reference

27 November 2017

issue

1-2

1 reference

27 November 2017

page(s)

170-181

1 reference

New insights into progressive supranuclear palsy

27 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2902244-8

Evidence for oxidative stress in the subthalamic nucleus in progressive supranuclear palsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2902244-8

Frontal lobe dysfunction in progressive supranuclear palsy: evidence for oxidative stress and mitochondrial impairment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2902244-8

Further evidence for mitochondrial dysfunction in progressive supranuclear palsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2902244-8

Association of an extended haplotype in the tau gene with progressive supranuclear palsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2902244-8

Energetics in the pathogenesis of neurodegenerative diseases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2902244-8

The free radical theory of aging matures

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2902244-8

Oxidative damage and metabolic dysfunction in Huntington's disease: selective vulnerability of the basal ganglia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2902244-8

Neurofibrillary pathology in progressive supranuclear palsy (PSP).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2902244-8

Enzymatic/nonenzymatic sources of oxyradicals and regulation of antioxidant defenses.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2902244-8

Genetic evidence for the involvement of tau in progressive supranuclear palsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2902244-8

The clinical and pathological spectrum of Steele-Richardson-Olszewski syndrome (progressive supranuclear palsy): a reappraisal

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2902244-8

Alterations in levels of iron, ferritin, and other trace metals in neurodegenerative diseases affecting the basal ganglia. The Royal Kings and Queens Parkinson's Disease Research Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2902244-8

Neuropathologic differentiation of progressive supranuclear palsy and corticobasal degeneration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2902244-8

Neurodegenerative disorders with extensive tau pathology: a comparative study and review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2902244-8

Epitope expression and hyperphosphorylation of tau protein in corticobasal degeneration: differentiation from progressive supranuclear palsy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2902244-8

Superoxide radical and superoxide dismutases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2902244-8

Multiple isoforms of human microtubule-associated protein tau: sequences and localization in neurofibrillary tangles of Alzheimer's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2902244-8

Oxidative stress: free radical production in neural degeneration.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2902244-8

L-DOPA up-regulates glutathione and protects mesencephalic cultures against oxidative stress.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2902244-8

Preliminary NINDS neuropathologic criteria for Steele-Richardson-Olszewski syndrome (progressive supranuclear palsy).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2902244-8

Glial cells protect neurons against oxidative stress via transcriptional up-regulation of the glutathione synthesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2902244-8

Manganese superoxide dismutase overexpression attenuates MPTP toxicity.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2902244-8

Inducible nitric oxide synthase (iNOS)-like immunoreactivity in argyrophilic, tau-positive astrocytes in progressive supranuclear palsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2902244-8

Neurodegeneration, myocardial injury, and perinatal death in mitochondrial superoxide dismutase-deficient mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2902244-8

Validity and reliability of the preliminary NINDS neuropathologic criteria for progressive supranuclear palsy and related disorders.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2902244-8

Clinical and genetic aspects of progressive supranuclear palsy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2902244-8

Deficit of brain and skeletal muscle bioenergetics in progressive supranuclear palsy shown in vivo by phosphorus magnetic resonance spectroscopy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2902244-8

4-Hydroxynonenal, a product of lipid peroxidation, inhibits dephosphorylation of the microtubule-associated protein tau.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2902244-8

Lipoperoxidation is selectively involved in progressive supranuclear palsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2902244-8

Superoxide dismutase is an abundant component in cell bodies, dendrites, and axons of motor neurons and in a subset of other neurons

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2902244-8

Glutathione is present in high concentrations in cultured astrocytes but not in cultured neurons

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2902244-8

Neurofibrillary degeneration in progressive supranuclear palsy and corticobasal degeneration: tau pathologies with exclusively "exon 10" isoforms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2902244-8

Alterations in glutathione levels in Parkinson's disease and other neurodegenerative disorders affecting basal ganglia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2902244-8

Strategies of antioxidant defense

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2902244-8

Histochemical evaluation of glutathione in brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2902244-8

PROGRESSIVE SUPRANUCLEAR PALSY. A HETEROGENEOUS DEGENERATION INVOLVING THE BRAIN STEM, BASAL GANGLIA AND CEREBELLUM WITH VERTICAL GAZE AND PSEUDOBULBAR PALSY, NUCHAL DYSTONIA AND DEMENTIA.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2902244-8

Mitochondrial dysfunction in cybrid lines expressing mitochondrial genes from patients with progressive supranuclear palsy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2902244-8

Progressive supranuclear palsy: a clinicopathological study of 21 cases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2902244-8

Fasting-induced depletion of glutathione in the aging mouse.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2902244-8

An immunohistochemical study on manganese superoxide dismutase in Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2902244-8

10.1016/S0006-8993(02)02244-8

7 January 2021

Identifiers

DOI

1 reference

27 November 2017

1 reference